224 related articles for article (PubMed ID: 27633132)
21. Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway.
Wang Q; Du J; Xu B; Xu L; Wang X; Liu J; Wang J
Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):501-8. PubMed ID: 27189511
[TBL] [Abstract][Full Text] [Related]
22. Temozolomide may induce cell cycle arrest by interacting with URG4/URGCP in SH-SY5Y neuroblastoma cells.
Çıtışlı V; Dodurga Y; Eroğlu C; Seçme M; Avcı ÇB; Şatıroğlu-Tufan NL
Tumour Biol; 2015 Sep; 36(9):6765-72. PubMed ID: 25835972
[TBL] [Abstract][Full Text] [Related]
23. Temozolomide induces the expression of the glioma Big Potassium (gBK) ion channel, while inhibiting fascin-1 expression: possible targets for glioma therapy.
Hoa NT; Ge L; Martini F; Chau V; Ahluwalia A; Kruse CA; Jadus MR
Expert Opin Ther Targets; 2016 Oct; 20(10):1155-67. PubMed ID: 27359377
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of protein phosphatase magnesium-dependent 1 (PPM1D) through lentivirus-mediated RNA silencing inhibits colorectal carcinoma cell proliferation.
Yin H; Yan Z; Liang Y; Liu B; Su Q
Technol Cancer Res Treat; 2013 Dec; 12(6):537-43. PubMed ID: 23745790
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas.
Yoshino A; Tashiro S; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Sano E; Tsumoto K
Int J Oncol; 2011 Sep; 39(3):529-42. PubMed ID: 21805051
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis.
Liu X; Kang J; Liu F; Wen S; Zeng X; Liu K; Luo Y; Ji X; Zhao S
Tumour Biol; 2016 May; 37(5):6323-30. PubMed ID: 26628298
[TBL] [Abstract][Full Text] [Related]
27. Juniperus Communis Extract Exerts Antitumor Effects in Human Glioblastomas Through Blood-Brain Barrier.
; Tsai NM; Chang KF; Wang JC
Cell Physiol Biochem; 2018; 49(6):2443-2462. PubMed ID: 30261501
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.
Zhou B; Bu G; Zhou Y; Zhao Y; Li W; Li M
Med Oncol; 2015 Jan; 32(1):378. PubMed ID: 25433945
[TBL] [Abstract][Full Text] [Related]
29. The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity.
Remington M; Chtchetinin J; Ancheta K; Nghiemphu PL; Cloughesy T; Lai A
Neuro Oncol; 2009 Feb; 11(1):22-32. PubMed ID: 18812520
[TBL] [Abstract][Full Text] [Related]
30. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
Zhuang D; Liu Y; Mao Y; Gao L; Zhang H; Luan S; Huang F; Li Q
Int J Cancer; 2012 Jan; 130(2):309-18. PubMed ID: 21328340
[TBL] [Abstract][Full Text] [Related]
31. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S
J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061
[TBL] [Abstract][Full Text] [Related]
32. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
Yang MC; Loh JK; Li YY; Huang WS; Chou CH; Cheng JT; Wang YT; Lieu AS; Howng SL; Hong YR; Chou AK
Int J Oncol; 2015 Mar; 46(3):1304-16. PubMed ID: 25586056
[TBL] [Abstract][Full Text] [Related]
33. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells.
Liu N; Hu G; Wang H; Li Z; Guo Z
J Cell Mol Med; 2018 Nov; 22(11):5300-5310. PubMed ID: 30133120
[TBL] [Abstract][Full Text] [Related]
34. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.
Atif F; Patel NR; Yousuf S; Stein DG
PLoS One; 2015; 10(6):e0131441. PubMed ID: 26110872
[TBL] [Abstract][Full Text] [Related]
35. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells.
Ma J; Yang YR; Chen W; Chen MH; Wang H; Wang XD; Sun LL; Wang FZ; Wang DC
Oncol Rep; 2016 Aug; 36(2):676-84. PubMed ID: 27278525
[TBL] [Abstract][Full Text] [Related]
36. Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity.
Kumar DM; Patil V; Ramachandran B; Nila MV; Dharmalingam K; Somasundaram K
Proteomics; 2013 Jul; 13(14):2113-24. PubMed ID: 23595970
[TBL] [Abstract][Full Text] [Related]
37. [Mechanism of temozolomide-induced anti-tumor effects on glioblastoma cells in vitro is via ROS-dependent SIRT1 signaling pathway].
Jiang Y; Sun Y; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):734-8. PubMed ID: 23291065
[TBL] [Abstract][Full Text] [Related]
38. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway.
Gielen PR; Aftab Q; Ma N; Chen VC; Hong X; Lozinsky S; Naus CC; Sin WC
Neuropharmacology; 2013 Dec; 75():539-48. PubMed ID: 23688923
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide.
Kanzawa T; Bedwell J; Kondo Y; Kondo S; Germano IM
J Neurosurg; 2003 Dec; 99(6):1047-52. PubMed ID: 14705733
[TBL] [Abstract][Full Text] [Related]
40. The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.
Zeng L; Kang C; Di C; Fee BE; Rivas M; Lin J; Adamson DC
Int J Oncol; 2014 Apr; 44(4):1243-51. PubMed ID: 24481586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
